 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
Quinidine is cited as one of the most frequent causes of drug-induced thrombocytopenia. This case report describes the use of high-dose intravenous gamma globulin to rapidly reverse quinidine-induced thrombocytopenia in a patient at increased risk for bleeding because of the presence of an antitachycardia pacemaker and an automatic implantable cardiac defibrillator. This report suggests that this treatment may aid in a more rapid reversal of quinidine-induced thrombocytopenia in patients at high risk of bleeding.
This article has been cited by other articles:
|
|
 |
|
  P. Pattis and C. J Wiedermann Ezetimibe-Associated Immune Thrombocytopenia Ann. Pharmacother., March 1, 2008; 42(3): 430 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Aster and D. W. Bougie Drug-Induced Immune Thrombocytopenia N. Engl. J. Med., August 9, 2007; 357(6): 580 - 587. [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
